Evidence map›Paper›PMID 42416217›Full record

ArticleHealth science reports2026

Clinical Significance of Tumor Invasion Gene Profiling in Early-Stage Hormone Receptor-Positive Breast Cancer: A Cross-Sectional Study.

Shayan Forghani, Hamid Rezvani, Arman Forghani, Fatemeh Mahdavi Sabet, Atieh Akbari, Sanaz Tabarestani, Hamid Reza Mirzaee

Abstract read
In one paragraph

Article in Health science reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Shayan ForghaniCancer Research Center Shahid Beheshti University of Medical Sciences Tehran Iran.
Hamid RezvaniDepartment of Hematology-oncology Shahid Beheshti University of Medical Sciences Tehran Iran.
Arman ForghaniCancer Research Center Shahid Beheshti University of Medical Sciences Tehran Iran.
Fatemeh Mahdavi SabetCancer Research Center Shahid Beheshti University of Medical Sciences Tehran Iran.ORCID https://orcid.org/0009-0007-4589-9688
Atieh AkbariCancer Research Center Shahid Beheshti University of Medical Sciences Tehran Iran.
Sanaz TabarestaniCancer Research Center Shahid Beheshti University of Medical Sciences Tehran Iran.ORCID https://orcid.org/0000-0002-8288-8116
Hamid Reza MirzaeeCancer Research Center Shahid Beheshti University of Medical Sciences Tehran Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Aims: Advanced breast cancer is a leading cause of cancer-associated death in women. It is critical to find biomarkers to identify patients who are more prone to progress to advanced disease and would be better served with more aggressive treatments. Hormone receptor-positive breast cancers make up about 70% of all breast cancers. The analysis of gene amplification and expression has been utilized to classify breast tumors into medically useful risk groups. In the present study, we selected five genes ( Methods: Two hundred and thirty-nine early-stage hormone receptor-positive breast cancer patients were analyzed. Patients were required to have FFPE (formalin-fixed paraffin-embedded) samples from the primary tumor. Expression of the selected genes was determined using TaqMan expression assays. Results: Expression of Conclusion: We found a significant association between

Indexed as

breast cancerCTSVgene expressionmetastasisMYBL2SCUBE2

Identifiers

PMID42416217
PMCPMC13338577

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.